Masimo Co. (NASDAQ:MASI) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System trimmed its position in Masimo Co. (NASDAQ:MASI - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 77,458 shares of the medical equipment provider's stock after selling 5,837 shares during the period. California Public Employees Retirement System owned 0.15% of Masimo worth $9,079,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Byrne Asset Management LLC purchased a new stake in shares of Masimo in the 4th quarter worth approximately $28,000. Massmutual Trust Co. FSB ADV raised its position in shares of Masimo by 140.6% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 243 shares of the medical equipment provider's stock worth $28,000 after purchasing an additional 142 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. bought a new position in Masimo in the 4th quarter worth about $36,000. NBC Securities Inc. bought a new position in Masimo in the 3rd quarter worth about $34,000. Finally, Fifth Third Bancorp grew its position in Masimo by 145.8% during the 4th quarter. Fifth Third Bancorp now owns 590 shares of the medical equipment provider's stock valued at $69,000 after purchasing an additional 350 shares during the last quarter. Institutional investors own 85.96% of the company's stock.

Masimo Stock Performance

MASI stock traded up $0.75 during trading on Friday, reaching $137.00. The stock had a trading volume of 590,602 shares, compared to its average volume of 549,672. The stock's 50 day moving average is $136.10 and its two-hundred day moving average is $118.25. The firm has a market cap of $7.25 billion, a PE ratio of 90.73 and a beta of 0.99. Masimo Co. has a 52 week low of $75.22 and a 52 week high of $188.76. The company has a current ratio of 2.18, a quick ratio of 1.22 and a debt-to-equity ratio of 0.64.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.82 by $0.43. Masimo had a net margin of 3.98% and a return on equity of 13.77%. The company had revenue of $548.90 million for the quarter, compared to the consensus estimate of $545.69 million. During the same quarter last year, the firm posted $1.32 earnings per share. The firm's revenue was down 11.0% compared to the same quarter last year. As a group, equities analysts anticipate that Masimo Co. will post 3.51 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. StockNews.com upgraded shares of Masimo from a "sell" rating to a "hold" rating in a research note on Friday, March 29th. BTIG Research boosted their price target on Masimo from $145.00 to $166.00 and gave the stock a "buy" rating in a research note on Monday, March 25th. Wells Fargo & Company raised Masimo from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $117.00 to $160.00 in a report on Monday, March 25th. Piper Sandler lifted their price objective on Masimo from $70.00 to $117.00 and gave the stock a "neutral" rating in a report on Monday, February 26th. Finally, Jefferies Financial Group restated a "hold" rating and set a $121.00 target price (up previously from $107.00) on shares of Masimo in a research note on Tuesday, January 30th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, Masimo currently has a consensus rating of "Hold" and an average price target of $137.43.

Insider Transactions at Masimo

In other Masimo news, Director Craig B. Reynolds sold 40,000 shares of the business's stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $136.17, for a total transaction of $5,446,800.00. Following the completion of the sale, the director now owns 7,406 shares of the company's stock, valued at $1,008,475.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 9.70% of the stock is currently owned by company insiders.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.